Hansa Biopharma AB (publ) financials at a glance

Year Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
kr0.00M kr0.10M kr2.98M kr4.45M kr3.01M kr5.33M kr1.79M kr1.62M kr6.68M kr2.58M kr3.44M kr3.36M kr3.36M kr6.10M kr33.88M kr154.53M kr134.09M kr0.00M
GM % Gross Margin %
0.00% 100.00% 92.63% 98.06% 96.95% 95.87% 78.67% 100.00% 90.14% 91.59% 93.58% 72.72% 74.26% 83.65% 54.47% 75.10% 52.91% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
kr-2.44 kr-2.26 kr-0.78 kr-0.79 kr-1.16 kr-1.78 kr-3.39 kr-4.97 kr-6.47 kr-9.00 kr-9.98 kr-12.33 kr-13.57 kr-15.83 kr0.00
Div. Dividends
kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00 kr0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares
0m 3.86m 3.86m 7.73m 13.52m 22.23m 22.23m 25.93m 32.41m 35.05m 37.81m 39.96m 40.03m 44.47m 44.47m 44.47m 0m 52.67m
OCF Operating Cash Flow
kr-6.28M kr-15.58M kr-13.79M kr-18.09M kr-27.14M kr-17.90M kr-14.83M kr-23.62M kr-57.80M kr-94.56M kr-150.11M kr-204.56M kr-334.78M kr-290.27M kr-481.17M kr-502.73M kr-755.65M kr0.00M
FCF Free Cash Flow
kr-6.36M kr-15.72M kr-13.80M kr-18.47M kr0.00M kr-27.19M kr-19.39M kr-24.94M kr-59.12M kr-95.49M kr-152.51M kr-207.05M kr-338.20M kr-290.57M kr-483.64M kr-507.51M kr-707.00M kr0.00M
FCFS Free Cash Flow Per Share
kr-3.15 kr-5.11 kr-3.45 kr-2.34 kr-2.50 kr-0.93 kr-0.64 kr-0.94 kr-1.89 kr-2.89 kr-4.28 kr-5.40 kr-8.45 kr-6.89 kr-10.87 kr-11.26 kr-14.39 kr0.00